Sagimet Biosciences Inc Series A (SGMT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 32,496 | 42,327 | 64,717 | 75,840 | 77,014 |
| Marketable Securities | 84,197 | 83,080 | 79,852 | 75,410 | 75,472 |
| TOTAL | $119,480 | $127,196 | $146,072 | $152,774 | $157,190 |
| Non-Current Assets | |||||
| Investments And Advances | 8,806 | 10,059 | 0 | 7,408 | 17,471 |
| Other Non-Current Assets | 115 | 152 | 100 | 77 | 114 |
| TOTAL | $8,921 | $10,211 | $100 | $7,485 | $17,585 |
| Total Assets | $128,401 | $137,407 | $146,172 | $160,259 | $174,775 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 4,243 | 1,921 | 3,223 | 1,425 | 1,152 |
| Accrued Expenses | 4,788 | 5,174 | 3,918 | 2,951 | 2,824 |
| TOTAL | $9,146 | $7,247 | $7,180 | $4,454 | $4,092 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $9,146 | $7,247 | $7,180 | $4,454 | $4,092 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 32,522 | 32,522 | 32,195 | 32,195 | 30,675 |
| Common Shares | 3 | 3 | 3 | 3 | 3 |
| Retained earnings | -336,781 | -323,873 | -313,487 | -295,311 | -279,110 |
| Other shareholders' equity | 117 | 76 | 121 | 230 | 441 |
| TOTAL | $119,255 | $130,160 | $138,992 | $155,805 | $170,683 |
| Total Liabilities And Equity | $128,401 | $137,407 | $146,172 | $160,259 | $174,775 |